Asthma drug in clinical trial to treat severe COVID-19 patients

Source: http://www.brainhealtheducation.org/asthma-drug-in-clinical-trial-to-treat-severe-covid-19-patients/

Yale researchers will begin a clinical trial at Yale-New Haven Hospital to test the effectiveness of a drug called ibudilast (MN-166) for treating acute respiratory distress syndrome (ARDS), a life-threatening lung condition developed by some of the most seriously ill COVID-19 patients. The researchers are part of Yale’s Advanced Therapies Group, which was formed in

Read More…

Source: http://www.brainhealtheducation.org/asthma-drug-in-clinical-trial-to-treat-severe-covid-19-patients/

Yale researchers will begin a clinical trial at Yale-New Haven Hospital to test the effectiveness of a drug called ibudilast (MN-166) for treating acute respiratory distress syndrome (ARDS), a life-threatening lung condition developed by some of the most seriously ill COVID-19 patients. The researchers are part of Yale’s Advanced Therapies Group, which was formed in

Read More…

What Do You Think?

comments

Translate »